The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin 10
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Treatment of Murine Colitis by Lactococcus lactis Secreting Interleukin-10
Steidler, L., Hans, W., Schotte, L., Neirynck, S., Obermeier, F., Falk, W., Fiers, W., & Remaut, E. (2000) · Science · doi:10.1126/science.289.5483.1352 · Cited by 1,513
Self-citationThe Complete Genome Sequence of the Lactic Acid Bacterium Lactococcus lactis ssp. lactis IL1403
Bolotin, A., Wincker, P., Mauger, S., Jaillon, O., Malarme, K., Weissenbach, J., Ehrlich, S. D., & Sorokin, A. (2001) · Genome Research · doi:10.1101/gr.gr-1697r · Cited by 1,139
The Complete Genome Sequence of the Lactic Acid Bacterium Lactococcus lactis ssp. lactis IL1403
Bolotin, A., Wincker, P., Mauger, S., Jaillon, O., Malarme, K., Weissenbach, J., Ehrlich, S. D., & Sorokin, A. (2001) · Genome Research · doi:10.1101/gr.169701 · Cited by 1,139
Single-step assembly of a gene and entire plasmid from large numbers of oligodeoxyribonucleotides
Stemmer, W. P. C., Crameri, A., Ha, K. D., Brennan, T. M., & Heyneker, H. L. (1995) · Gene · doi:10.1016/0378-1119(95)00511-4 · Cited by 728
Fedorak, R. N., Gangl, A., Elson, C. O., Rutgeerts, P., Schreiber, S., Wild, G., Hanauer, S. B., Kilian, A., Cohard, M., LeBeaut, A., et al. (2000) · Gastroenterology · doi:10.1053/gast.2000.20229 · Cited by 512
Interleukin 10: a novel stimulatory factor for mast cells and their progenitors.
Thompson-Snipes, L., Dhar, V, Bond, M. W., Mosmann, T. R., Moore, K. W., & Rennick, D. M. (1991) · The Journal of experimental medicine · doi:10.1084/jem.173.2.507 · Cited by 495
van Deventer, S., Elson, C., & Fedorak, R. (1997) · Gastroenterology · doi:10.1053/gast.1997.v113.pm9247454 · Cited by 486
Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease
Schreiber, S., Fedorak, R. N., Nielsen, O. H., Wild, G., Williams, C. N., Nikolaus, S., Jacyna, M., Lashner, B. A., Gangl, A., Rutgeerts, P., et al. (2000) · Gastroenterology · doi:10.1053/gast.2000.20196 · Cited by 458
High-efficiency gene inactivation and replacement system for gram-positive bacteria
Biswas, I., Gruss, A., Ehrlich, S. D., & Maguin, E. (1993) · Journal of Bacteriology · doi:10.1128/jb.175.11.3628-3635.1993 · Cited by 443
Law, J., Buist, G., Haandrikman, A., Kok, J., Venema, G., & Leenhouts, K. (1995) · Journal of Bacteriology · doi:10.1128/jb.177.24.7011-7018.1995 · Cited by 327
Cited by
Bio-inspired, bioengineered and biomimetic drug delivery carriers
Yoo, J.-W., Irvine, D. J., Discher, D. E., & Mitragotri, S. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3499 · Cited by 1,236
Emerging Frontiers in Drug Delivery
Tibbitt, M. W., Dahlman, J. E., & Langer, R. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.5b09974 · Cited by 975
A Phase I Trial With Transgenic Bacteria Expressing Interleukin-10 in Crohn’s Disease
Braat, H., Rottiers, P., Hommes, D. W., Huyghebaert, N., Remaut, E., Remon, J., van Deventer, S. J. H., Neirynck, S., Peppelenbosch, M. P., & Steidler, L. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.03.028 · Cited by 786
Self-citationProbiotic use in clinical practice: what are the risks?
Boyle, R. J., Robins-Browne, R. M., & Tang, M. L. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.6.1256 · Cited by 776
Inflammatory bowel diseases (IBD) and the microbiome-searching the crime scene for clues
Lee, M., & Chang, E. B. (2021) · Gastroenterology · doi:10.1053/j.gastro.2020.09.056 · Cited by 645
Programmable cells: Interfacing natural and engineered gene networks
Kobayashi, H., Kærn, M., Araki, M., Chung, K., Gardner, T. S., Cantor, C. R., & Collins, J. J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402940101 · Cited by 602
Mucosal delivery of therapeutic and prophylactic molecules using lactic acid bacteria
Wells, J. M., & Mercenier, A. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro1840 · Cited by 537
Mouse models of inflammatory bowel disease☆
WIRTZ, S., & NEURATH, M. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.07.003 · Cited by 507
Engineered living biomaterials
Rodrigo-Navarro, A., Sankaran, S., Dalby, M. J., del Campo, A., & Salmeron-Sanchez, M. (2021) · Nature Reviews Materials · doi:10.1038/s41578-021-00350-8 · Cited by 494
Biocontainment of genetically modified organisms by synthetic protein design
Mandell, D. J., Lajoie, M. J., Mee, M. T., Takeuchi, R., Kuznetsov, G., Norville, J. E., Gregg, C. J., Stoddard, B. L., & Church, G. M. (2015) · Nature · doi:10.1038/nature14121 · Cited by 470
Engineering bacteria for diagnostic and therapeutic applications
Riglar, D. T., & Silver, P. A. (2018) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.172 · Cited by 460
A review on Lactococcus lactis: from food to factory
Song, A. A.-L., In, L. L. A., Lim, S. H. E., & Rahim, R. A. (2017) · Microbial Cell Factories · doi:10.1186/s12934-017-0669-x · Cited by 414
Wegmann, U., O'Connell-Motherway, M., Zomer, A., Buist, G., Shearman, C., Canchaya, C., Ventura, M., Goesmann, A., Gasson, M. J., Kuipers, O. P., et al. (2007) · Journal of Bacteriology · doi:10.1128/jb.01768-06 · Cited by 415
(Dis)Trust your gut: the gut microbiome in age-related inflammation, health, and disease
Buford, T. W. (2017) · Microbiome · doi:10.1186/s40168-017-0296-0 · Cited by 409
'Deadman' and 'Passcode' microbial kill switches for bacterial containment
Chan, C. T. Y., Lee, J. W., Cameron, D. E., Bashor, C. J., & Collins, J. J. (2016) · Nature Chemical Biology · doi:10.1038/nchembio.1979 · Cited by 399
Mimee, M., Tucker, A. C., Voigt, C. A., & Lu, T. K. (2015) · Cell Systems · doi:10.1016/j.cels.2015.06.001 · Cited by 387
Nucleotide metabolism and its control in lactic acid bacteria
Kilstrup, M., Hammer, K., Jensen, P. R., & Martinussen, J. (2005) · FEMS Microbiology Reviews · doi:10.1016/j.femsre.2005.04.006 · Cited by 377
Recoded organisms engineered to depend on synthetic amino acids
Rovner, A. J., Haimovich, A. D., Katz, S. R., Li, Z., Grome, M. W., Gassaway, B. M., Amiram, M., Patel, J. R., Gallagher, R. R., Rinehart, J., et al. (2015) · Nature · doi:10.1038/nature14095 · Cited by 363
Cross-Talk between Probiotic Bacteria and the Host Immune System1,
Corthésy, B., Gaskins, H. R., & Mercenier, A. (2007) · The Journal of Nutrition · doi:10.1093/jn/137.3.781s · Cited by 351
Microbiome therapeutics — Advances and challenges
Mimee, M., Citorik, R. J., & Lu, T. K. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.04.032 · Cited by 317
Targeting IL-10 Family Cytokines for the Treatment of Human Diseases
Wang, X., Wong, K., Ouyang, W., & Rutz, S. (2019) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a028548 · Cited by 302
Probiotics: Properties, Examples, and Specific Applications
Behnsen, J., Deriu, E., Sassone-Corsi, M., & Raffatellu, M. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a010074 · Cited by 293
Drug delivery strategies in the therapy of inflammatory bowel disease
Lautenschläger, C., Schmidt, C., Fischer, D., & Stallmach, A. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.10.001 · Cited by 291
Orally administered L. lactis secreting an anti-TNF Nanobody demonstrate efficacy in chronic colitis
Vandenbroucke, K., de Haard, H., Beirnaert, E., Dreier, T., Lauwereys, M., Huyck, L., Van Huysse, J., Demetter, P., Steidler, L., Remaut, E., et al. (2010) · Mucosal Immunology · doi:10.1038/mi.2009.116 · Cited by 289
Self-citationVandenbroucke, K., Hans, W., Van Huysse, J., Neirynck, S., Demetter, P., Remaut, E., Rottiers, P., & Steidler, L. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.05.020 · Cited by 277
Self-citationIL-10 and its related cytokines for treatment of inflammatory bowel disease
Li, M.-C. (2004) · World Journal of Gastroenterology · doi:10.3748/wjg.v10.i5.620 · Cited by 277
Role of commensal and probiotic bacteria in human health: a focus on inflammatory bowel disease
Martín, R., Miquel, S., Ulmer, J., Kechaou, N., Langella, P., & Bermúdez-Humarán, L. G. (2013) · Microbial Cell Factories · doi:10.1186/1475-2859-12-71 · Cited by 270
Next-generation biocontainment systems for engineered organisms
Lee, J. W., Chan, C. T. Y., Slomovic, S., & Collins, J. J. (2018) · Nature Chemical Biology · doi:10.1038/s41589-018-0056-x · Cited by 270
Engineering Bacteria‐Activated Multifunctionalized Hydrogel for Promoting Diabetic Wound Healing
Lu, Y., Li, H., Wang, J., Yao, M., Peng, Y., Liu, T., Li, Z., Luo, G., & Deng, J. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202105749 · Cited by 262
Food-Grade Bacteria Expressing Elafin Protect Against Inflammation and Restore Colon Homeostasis
Motta, J.-P., Bermúdez-Humarán, L. G., Deraison, C., Martin, L., Rolland, C., Rousset, P., Boue, J., Dietrich, G., Chapman, K., Kharrat, P., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004212 · Cited by 257
Recent understanding of IBD pathogenesis: Implications for future therapies
Kucharzik, T., Maaser, C., Lügering, A., Kagnoff, M., Mayer, L., Targan, S., & Domschke, W. (2006) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000235827.21778.d5 · Cited by 254
Nano- and microparticulate drug carriers for targeting of the inflamed intestinal mucosa
Collnot, E.-M., Ali, H., & Lehr, C.-M. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.01.028 · Cited by 254
Protease inhibition as new therapeutic strategy for GI diseases
Vergnolle, N. (2016) · Gut · doi:10.1136/gutjnl-2015-309147 · Cited by 226
The genomics of lactic acid bacteria
Pfeiler, E. A., & Klaenhammer, T. R. (2007) · Trends in Microbiology · doi:10.1016/j.tim.2007.09.010 · Cited by 192
Oral colon-specific therapeutic approaches toward treatment of inflammatory bowel disease
Xiao, B., & Merlin, D. (2012) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2012.730517 · Cited by 145
Design and regulation of engineered bacteria for environmental release
Chemla, Y., Sweeney, C. J., Wozniak, C. A., & Voigt, C. A. (2025) · Nature Microbiology · doi:10.1038/s41564-024-01918-0 · Cited by 142
Huys, G., Botteldoorn, N., Delvigne, F., De Vuyst, L., Heyndrickx, M., Pot, B., Dubois, J., & Daube, G. (2013) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201300065 · Cited by 132
Hamady, Z. Z. R., Scott, N., Farrar, M. D., Lodge, J. P. A., Holland, K. T., Whitehead, T., & Carding, S. R. (2010) · Gut · doi:10.1136/gut.2008.176131 · Cited by 131
Fourth generation biofuel from genetically modified algal biomass: Challenges and future directions.
Shokravi, H., Shokravi, Z., Heidarrezaei, M., Ong, H. C., Rahimian Koloor, S. S., Petrů, M., Lau, W. J., & Ismail, A. F. (2021) · Chemosphere · doi:10.1016/j.chemosphere.2021.131535 · Cited by 127
Endostatin gene therapy delivered by Salmonella choleraesuis in murine tumor models
Lee, C., Wu, C., & Shiau, A. (2004) · The Journal of Gene Medicine · doi:10.1002/jgm.626 · Cited by 93
Genetically Engineered Microorganisms and Their Impact on Human Health
Mahdizade Ari, M., Dadgar, L., Elahi, Z., Ghanavati, R., & Taheri, B. (2024) · International Journal of Clinical Practice · doi:10.1155/2024/6638269 · Cited by 67
Use of genetically modified bacteria for drug delivery in humans: Revisiting the safety aspect
Wegmann, U., Carvalho, A. L., Stocks, M., & Carding, S. R. (2017) · Scientific Reports · doi:10.1038/s41598-017-02591-6 · Cited by 53
Metadata
- Authors
- Steidler, L., Neirynck, S., Huyghebaert, N., Snoeck, V., Vermeire, A., Goddeeris, B., Cox, E., Remon, J. P., & Remaut, E.
- Venue
- Nature Biotechnology
- Published
- 2003-06-15
- Volume
- 21
- Issue
- 7
- Pages
- 785-789
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- OpenAlex
- W2089075037
- Cited by
- 542
- References
- 29
- FWCI
- 46.84
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.